Market News / Story
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
GlobeNewswire ·
GlobeNewswire reports: Collaboration will educate physicians and prostate cancer centers on the complementary roles of Telix’s PSMA-PET molecular imaging technologies and Profound’s MRI-guided TULSA-PRO ® Agreement provides Profound with increased access to urologists via a strong strategic partner and creates a framework to further advance clinical evidence-based patient selection and optimization of patient treatment plans TORONTO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp.…
Related stories
China And The EU Have Come To An Agreement To Better Handle Trade DisputesRead story summary
China And The Eu Have Come To An Agreement To Better Handle Trade Disputes. China And The Eu Have Agreed On Hybrid Vehicle Trade Following Extensive Talks, In Line With Wto Rules. Discussions Will Continue On Price Terms And The Eu's Anti-subsidy Inquiry Into Chinese Electric Cars. China commerce ministry to keep exploring scope to cut tariffs on some goods under WTO rules
VIEW SOURCE